Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,701.16
(
0.65%
)
News Focus
News Focus

Replies to post #764295 on NorthWest Biotherapeutics Inc (NWBO)

Replies to #764295 on NorthWest Biotherapeutics Inc (NWBO)
icon url

theswordman

04/27/25 5:33 PM

#764322 RE: Galzus Research #764295

DCVax-L is anticipated to be the top revenue-generating therapy among all, with ONC-201 following closely in the 7MM by 2034.